Phase 1 Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to sign a consent form agreeing to take part in the study
- You are 18 years of age or older
- If you are a woman who could become pregnant, you must agree to use highly effective birth control during the study and for 30 days after your last dose, and must have 2 negative pregnancy tests before starting (at least one must be a blood test)
- If you are a woman who cannot become pregnant, this applies if you have been through menopause or have had a surgical procedure to prevent pregnancy
- If you are a man, you must agree to ensure your female partner uses highly effective birth control during the study and for at least 30 days after your last dose, and you must not donate sperm during this time
- You have an advanced solid tumour cancer that has not responded to standard treatments, or no standard treatment is available for your cancer
- In Part 1 of the study, any type of advanced solid tumour is eligible; in Part 2, your tumour must have a specific gene change called a BRAF mutation, or you must have liver cancer (HCC)
- You have at least one tumour that can be measured using standard imaging scans
- You are generally well enough to carry out light daily activities (this is measured using a standard scale called ECOG, with a score of 0 or 1)
Who may not be able to join:
- You have a serious medical condition, abnormal lab results, or a mental health condition that could make it unsafe for you to participate
- You have a condition that could make it difficult for doctors to understand the results of the study
- You are currently pregnant or breastfeeding
- You have received treatment for another cancer (including chemotherapy, radiation, or antibody therapy) within a recent short period before starting this study (confirm with trial site for exact timeframes)
- You have brain metastases (cancer that has spread to the brain) that are causing symptoms, are unstable, or require treatment such as steroids that have recently been increased
- You have a significant heart or blood vessel condition
- You have an active infection that requires ongoing medication within 2 weeks of starting the study
- You have HIV, AIDS, or an active hepatitis B or hepatitis C infection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-21-60799565
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of dose limiting toxicity (DLT); Incidence of adverse events (AEs) and serious AEs (SAEs) as assessed by CTCAE v5.0
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.